Genalyte, a San Diego life sciences company that develops and commercializes multiplexing technology, has secured a $12 million round of funding from Redmile Group and Claremont Creek Ventures. The company uses silicon chip manufacturing methods for immunodetection; it’s launching a commercial platform for the autoimmunity research and testing markets this summer. [Source: MarketWatch]